October is Breast Cancer Awareness Month, a good time to review and share the screening options for breast cancer. In the U.S., around one in eight women will develop breast cancer during their lifetime, while for men that figure is
PETNET is presenting a complimentary webcast titled “A Novel Option for Biochemically Recurrent Prostate Cancer Diagnosis” on October 17th. The webinar will include an overview of recurrent prostate cancer, discussion of detecting and localizing recurrent prostate cancer, a review of
NETSPOT (68Ga-Dotatate) is a radioactive diagnostic agent used for PET imaging that is gaining ground among practices. FDA-approved in 2016, NETSPOT is used in imaging to locate somatostatin receptor positive neuroendocrine tumors in adult and pediatric patients. The commercial product
Physicians are often faced with diagnostic situations for which it is important to order the right type of neuroimaging. One of the most common decisions is whether to use MRI or CT scans. Both types of imaging are capable of
What is theranostics in nuclear medicine? Theranostics is a new term in the field of medicine, but gaining considerable traction. The concept of theranostics refers to the integration of therapeutics and diagnostics in one package. For example, with imaging and
What are you getting when you choose either digital or analog MRI? Patients and physicians often have questions. After all, everyone wants to ensure that they have the best possible chance for an accurate and timely diagnosis. The underlying message
CONNECT WITH DMS
©2019 DMS Health Technologies
